Epigenomics (EPGNF)

[jupp]

Epigenomics Establishes American Depositary Receipt (ADR) Program

09.07.2013

Epigenomics ADRs can be traded on US over-the-counter (OTC) market effective as of July 9, 2013
ADR ticker symbol EPGNY
1 ADR represents 5 ordinary company shares
Berlin, Germany, and U.S.A. - Epigenomics AG (Frankfurt Prime Standard: ECX), the German-American cancer molecular diagnostics company, today announced that the Company has established a Level 1 ADR program in the U.S.A. BNY Mellon has been appointed as the depositary bank for the ADR program. ADRs of Epigenomics are US dollar negotiable certificates representing ordinary shares of the Company at a ratio of five ordinary shares to one Epigenomics ADR. Epigenomics ADRs can be traded on the US OTC market effective as of July 9, 2013 under the ticker symbol EPGNY. Ordinary Epigenomics shares are traded in Frankfurt Prime Standard, Germany, under the ticker symbol ECX.